Ingrid Bartholomeus is a seasoned professional in clinical research and quality management, currently serving as Clinical Quality Associate Director at AstraZeneca since January 2018, after progressing through roles such as Clinical Quality Manager. Prior experience includes significant positions at Astellas Pharma Europe, where Ingrid held titles such as Senior Study Manager and Associate Director of Clinical Site Management, and at Pfizer as a CRA/CRA coach. Ingrid's career began at SmithKline Beecham, advancing to the role of Head of the Clinical Development Unit. Ingrid holds a medical degree from Utrecht University, earned between 1978 and 1985.